Simcere Pharmaceutical Group Ltd
Simcere Pharmaceutical Group's GHG Emissions Data Preview
In 2023, Simcere Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Simcere Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Simcere Pharmaceutical Group’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Simcere Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.
Insights into Simcere Pharmaceutical Group's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Simcere Pharmaceutical Group amounted to 67,632.68 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Simcere Pharmaceutical Group decreased by 2.34%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Simcere Pharmaceutical Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Simcere Pharmaceutical Group's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Simcere Pharmaceutical Group were 4,996.5 metric tons of CO₂ equivalent (tCO₂e). a
Has Simcere Pharmaceutical Group reduced its Scope 1 emissions over time?
Since 2020, Simcere Pharmaceutical Group's Scope 1 emissions have increased by 3.68%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2022), Simcere Pharmaceutical Group's Scope 1 emissions decreased by 5.38%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Simcere Pharmaceutical Group's Scope 2 emissions?
In 2023, Simcere Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 62,636.18 tCO₂e without specifying the calculation method. a
Has Simcere Pharmaceutical Group reduced its Scope 2 emissions over time?
Since 2020, Simcere Pharmaceutical Group's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Simcere Pharmaceutical Group 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2022), Simcere Pharmaceutical Group's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Simcere Pharmaceutical Group 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Simcere Pharmaceutical Group use for Scope 2 reporting?
In 2023, Simcere Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology. a
Simcere Pharmaceutical Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Simcere Pharmaceutical Group’s GHG Emissions Intensity Compared to Industry Peers
In 2023, Simcere Pharmaceutical Group reported Scope 1 greenhouse gas (GHG) emissions of 4,996.5 tCO₂e and total revenues of USD 1,017 millions. This translates into an emissions intensity of 4.91 tCO₂e per millions USD. a
Simcere Pharmaceutical Group's Scope 1 Emissions Intensity Compared to Peers
How does Simcere Pharmaceutical Group's GHG emissions intensity compare to its peers?
In 2023, Simcere Pharmaceutical Group reported a Scope 1 emissions intensity of 4.91 tCO₂e per millions USD. Compared to the peer group median of 25.27 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Simcere Pharmaceutical Group rank on GHG emissions intensity within its industry?
In 2023, Simcere Pharmaceutical Group ranked 4 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Simcere Pharmaceutical Group among the top performers, with one of the lowest emissions intensities relative to peers. a